IMPACT OF A PRIOR AUTHORIZATION FOR PREGABALIN ON HEALTH PLAN DRUG EXPENDITURES

被引:0
|
作者
Bazalo, G. [1 ]
Weiss, R. C. [2 ]
Joshi, A., V [3 ]
机构
[1] Managed Solut LLC, Conifer, CO USA
[2] Managed Solut LLC, Randolph, NJ USA
[3] Pfizer Inc, New York, NY USA
关键词
D O I
10.1016/S1098-3015(10)73008-4
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A206 / A206
页数:1
相关论文
共 50 条
  • [41] Impact of formulary restriction with prior authorization by an antimicrobial stewardship program
    Reed, Erica E.
    Stevenson, Kurt B.
    West, Jessica E.
    Bauer, Karri A.
    Goff, Debra A.
    VIRULENCE, 2013, 4 (02) : 158 - 162
  • [42] Cost impact of a prior authorization restriction on pimecrolimus 1% cream
    Mahajan, S
    Chang, J
    Raut, M
    Sung, J
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB86 - AB86
  • [43] Medications requiring prior authorization across health insurance plans
    Jones, Laney K.
    Ladd, Ilene G.
    Gionfriddo, Michael R.
    Gregor, Christina
    Evans, Michael A.
    Graham, Jove
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2020, 77 (08) : 644 - 648
  • [44] Prior authorization for diabetes medications: Clinical outcomes and health disparities
    Salter, Ella
    Louks, Aimee
    Pham, Catherine
    Arenz, Barbara
    Delate, Thomas
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2024, 18 (02)
  • [45] Association between insurance plan, prior authorization, and time to receipt of oral anticancer drugs
    Lichtenstein, Morgan R. L.
    Beauchemin, Melissa Parsons
    Raghunathan, Rohit R.
    Doshi, Sahil D.
    Law, Cynthia
    Accordino, Melissa Kate
    Elkin, Elena B.
    Wright, Jason Dennis
    Hershman, Dawn L.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [46] Pharmacy resident involvement in prior-authorization drug request adjudication
    Britnell, Sara R.
    Brown, Jamie N.
    Hashem, Mohamed G.
    Hale, Jonathan C.
    Bryan, William E.
    Hammond, Julie M.
    Britt, Rachel B.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2018, 75 (23) : S87 - S92
  • [47] COMPARISON OF HEALTH EXPENDITURES AND DRUG EXPENDITURES IN TWO WESTERN BALKAN COUNTRIES
    Gavrankapetanovic, F.
    Krehic, J.
    Oruc, L.
    VALUE IN HEALTH, 2012, 15 (07) : A612 - A612
  • [48] Impact of a step-therapy protocol for pregabalin on healthcare utilization and expenditures in a commercial population
    Udall, Margarita
    Louder, Anthony
    Suehs, Brandon T.
    Cappelleri, Joseph C.
    Joshi, Ashish V.
    Patel, Nick C.
    JOURNAL OF MEDICAL ECONOMICS, 2013, 16 (06) : 784 - 792
  • [49] Impact of implementing electronic prior authorization on medication filling in an electronic health record system in a large healthcare system
    Lauffenburger, Julie C.
    Stults, Cheryl D.
    Mudiganti, Satish
    Yan, Xiaowei
    Dean-Gilley, Lisa M.
    He, Mengdong
    Tong, Angela
    Fischer, Michael A.
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2021, 28 (10) : 2233 - 2240
  • [50] Understanding profiles of patients with treatment-resistant depression by stringency of health plan prior authorization criteria for approval of esketamine nasal spray
    Harding, Lisa
    Zhdanava, Maryia
    Shah, Aditi
    Pesa, Jacqueline
    Totev, Todor I.
    Tardif-Samson, Anabelle
    Pilon, Dominic
    Joshi, Kruti
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (09) : 1615 - 1623